BG45219A3 - Метод за получаване на вектор на рекомбинантна днк,съдържащ част от изопеницилин синтеза на цефалоспориум акремониум - Google Patents

Метод за получаване на вектор на рекомбинантна днк,съдържащ част от изопеницилин синтеза на цефалоспориум акремониум

Info

Publication number
BG45219A3
BG45219A3 BG078442A BG7844286A BG45219A3 BG 45219 A3 BG45219 A3 BG 45219A3 BG 078442 A BG078442 A BG 078442A BG 7844286 A BG7844286 A BG 7844286A BG 45219 A3 BG45219 A3 BG 45219A3
Authority
BG
Bulgaria
Prior art keywords
isopenicillin
obtaining
vector containing
recombinant dna
dna vector
Prior art date
Application number
BG078442A
Other languages
Bulgarian (bg)
English (en)
Inventor
Thomas Ingolia
Stephen Queener
Suellen Samson
Paul Skatrud
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG45219A3 publication Critical patent/BG45219A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
BG078442A 1985-04-22 1986-04-18 Метод за получаване на вектор на рекомбинантна днк,съдържащ част от изопеницилин синтеза на цефалоспориум акремониум BG45219A3 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72587085A 1985-04-22 1985-04-22
US79938485A 1985-11-18 1985-11-18

Publications (1)

Publication Number Publication Date
BG45219A3 true BG45219A3 (bg) 1989-04-14

Family

ID=27111238

Family Applications (2)

Application Number Title Priority Date Filing Date
BG078442A BG45219A3 (bg) 1985-04-22 1986-04-18 Метод за получаване на вектор на рекомбинантна днк,съдържащ част от изопеницилин синтеза на цефалоспориум акремониум
BG074576A BG45047A3 (bg) 1985-04-22 1986-04-18 Метод за получаване на изопеницилин н синтетазна активност в гостоприемникова клетка

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG074576A BG45047A3 (bg) 1985-04-22 1986-04-18 Метод за получаване на изопеницилин н синтетазна активност в гостоприемникова клетка

Country Status (14)

Country Link
EP (1) EP0200425B1 (pt)
JP (1) JPH0787788B2 (pt)
KR (1) KR860008287A (pt)
CN (1) CN86102604A (pt)
AU (2) AU592791B2 (pt)
BG (2) BG45219A3 (pt)
CA (1) CA1309673C (pt)
DE (1) DE3683080D1 (pt)
DK (1) DK178386A (pt)
ES (3) ES8800344A1 (pt)
FI (1) FI95810C (pt)
HU (1) HU202279B (pt)
IE (1) IE58780B1 (pt)
IL (1) IL78531A0 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR860001471B1 (ko) 1980-04-03 1986-09-26 비오겐 엔. 브이 인체의 섬유아세포 인터페론(IFN-β)폴리펩티드의 제조방법
GB8508800D0 (en) * 1985-04-04 1985-05-09 Glaxo Group Ltd Microbiological process
US4892819A (en) * 1985-11-25 1990-01-09 Eli Lilly And Company Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N synthetase from penicillium chrysogenum
DE3789880T2 (de) * 1986-01-31 1994-09-08 Beecham Group Plc Isolierung und Expression von bei der Biosynthese von Beta-Laktamen beteiligten Genen.
IL85535A (en) * 1987-03-04 1994-02-27 Lilly Co Eli AND Recombinant expression vectors encoding datastoxysplosporin C synthetase and datacetylsephalosporin C synthetase
GB2208077A (en) * 1987-04-24 1989-02-22 Antibioticos Sa Isopenicillin n synthetase gene derived from aspergillus nidulans
EP0303364A1 (en) * 1987-08-10 1989-02-15 The Governors of the University of Alberta Cloning and nucleotide sequence determination of the isopenicillin N synthetase gene from streptomyces clavuligerus
US4885252A (en) * 1987-09-08 1989-12-05 Eli Lilly And Company Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N synthetase from aspergillus nidulans
US4950603A (en) * 1987-11-02 1990-08-21 Eli Lilly And Company Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N synthetase from Streptomyces lipmanii
US6258555B1 (en) 1987-12-09 2001-07-10 Beecham Group P.L.C. DNA encoding ACV synthetase
GB8728811D0 (en) * 1987-12-09 1988-01-27 Beecham Group Plc Novel substance
KR0171897B1 (ko) * 1989-12-27 1999-02-01 후지사와 도모끼찌로 7-아미노세펨 화합물 또는 그 염류의 제조 방법
ATE180279T1 (de) * 1990-01-12 1999-06-15 Glaxo Group Ltd Für ein enzym der antibiotika-biosynthese kodierende dna-sequenz
US5882883A (en) * 1994-09-28 1999-03-16 Novo Nordisk A/S Process for the production of secondary metabolites
DE19755302A1 (de) * 1997-12-12 1999-06-17 Hoechst Marion Roussel De Gmbh Neuer Transkriptionsfaktor CPCR1 zur Regulation des Isopenicillin N-Synthetase-Gens (pcbC) und des AC-/ACV-Synthetase-Gens (pcbAB)
EP1165546A2 (en) * 1999-04-02 2002-01-02 Du Pont Pharmaceuticals Company Novel lactam inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3330003A1 (de) * 1982-10-21 1984-10-31 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Dna-sequenz und dna-strukturen und sie verwendendes verfahren zur herstellung von penicillin-acylase
CA1278540C (en) * 1983-07-22 1991-01-02 Eli Lilly And Company Modified antibiotic resistance gene
US4762786A (en) * 1984-09-27 1988-08-09 Eli Lilly And Company Vectors and conditions which allow genetic transformation of cephalosporium
GB8508800D0 (en) * 1985-04-04 1985-05-09 Glaxo Group Ltd Microbiological process
US4892819A (en) * 1985-11-25 1990-01-09 Eli Lilly And Company Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N synthetase from penicillium chrysogenum

Also Published As

Publication number Publication date
ES8900142A1 (es) 1989-01-16
FI95810C (fi) 1996-03-25
ES8800344A1 (es) 1987-11-01
EP0200425A3 (en) 1988-07-06
ES554218A0 (es) 1987-11-01
ES557658A0 (es) 1988-08-16
KR860008287A (ko) 1986-11-14
BG45047A3 (bg) 1989-03-15
DK178386A (da) 1986-10-23
AU5643186A (en) 1986-10-30
AU619596B2 (en) 1992-01-30
IE58780B1 (en) 1993-11-17
AU592791B2 (en) 1990-01-25
JPS61254192A (ja) 1986-11-11
HUT40705A (en) 1987-01-28
JPH0787788B2 (ja) 1995-09-27
FI95810B (fi) 1995-12-15
CA1309673C (en) 1992-11-03
HU202279B (en) 1991-02-28
ES8802585A1 (es) 1988-08-16
AU4234789A (en) 1990-01-11
EP0200425A2 (en) 1986-11-05
CN86102604A (zh) 1986-11-26
IL78531A0 (en) 1986-08-31
DE3683080D1 (de) 1992-02-06
DK178386D0 (da) 1986-04-18
EP0200425B1 (en) 1991-12-27
FI861653A (fi) 1986-10-23
ES557829A0 (es) 1989-01-16
FI861653A0 (fi) 1986-04-18
IE861029L (en) 1986-10-22

Similar Documents

Publication Publication Date Title
BG45219A3 (bg) Метод за получаване на вектор на рекомбинантна днк,съдържащ част от изопеницилин синтеза на цефалоспориум акремониум
ES2013324A6 (es) Un metodo mejorado para producir una proteina heterologa.
AU6078986A (en) An alkaline protease, a process for the preparation of hybrid vectors and genetically transformed microorganisms
BG60107B2 (bg) Метод за получаване на еукариотен полипептид
BR0008772B1 (pt) vetor de expressão, célula bacteriana ou fúngica cultivada, processos para expandir in vitro células hematopoiéticas e progenitores de células hematopoiéticas, e para detectar a presença de rna de ligando zalfa11 e de ligando zalfa 11 in vitro em uma amostra biológica.
AU7575487A (en) Method for the preparation of proteins with factor VIII activity by microbial host cells; expression, vectors, host cells, antibodies
AU2670688A (en) Co-expression in eukaryotic cells
DE3369159D1 (en) Separation of plasma proteins from cell culture systems
EP0076647A3 (en) Culture media for cells originating from the immune system
ATE63335T1 (de) Herstellung von rekombinantem protein.
EP0152030A3 (en) Adult t cell leukemia virus antigen polypeptide
Uehara et al. Negamycin inhibits termination of protein synthesis directed by phage f2 RNA in vitro
AU586874B2 (en) Invasive microorganisms
IE40221L (en) Influenza vaccines
IL78270A (en) Dedicated ribosomes and their use
EP0284205A3 (en) Carbomycin biosynthetic gene, designated carg, for use in streptomyces and other organisms
DE69023101D1 (de) Bakterielles Kollagenase-Gen.
AU6295390A (en) Cell culture methods for producing activated protein c
Ainsworth et al. The incorporation of cytochrome oxidase into newly-forming yeast mitochondrial membranes
WO1988009809A3 (en) Cell system for expression of recombinant protein without production of virus
HERCHER et al. Rapid identification of micro-organisms(Final Report, 5 Apr. 1982- 31 May 1985)
ATE282701T1 (de) Rekombinante dnase b aus streptococcus pyogenes
AU5752390A (en) Method for culturing cells
KR890000671A (ko) 고정화된 유전자재조합 균주를 이용한 세팔렉신 및 6-apa의 제조방법